Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

44.47 -0.85 (-1.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 677,393
Open 45.06
Bid (Size) 44.12 (300)
Ask (Size) 45.99 (200)
Prev. Close 45.32
Today's Range 43.80 - 45.38
52wk Range 20.85 - 54.85
Shares Outstanding 37,037,453
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HARROW INC (NASDAQ:HROW) Emerges as a High-Growth Momentum Stock with Strong Technical Setup ↗
Via Chartmill
News headline image
Private Equity-Style Fund Buys $15.7 Million in Harrow Stock as Revenue Jumps 45% ↗
Harrow’s accelerating revenue and expanding product portfolio may help explain why a fundamentals-focused investment firm just made it a new position. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
-10.9%
-10.9%
1 Month
-11.3%
-11.3%
3 Month
+15.4%
+15.4%
6 Month
+22.9%
+22.9%
1 Year
+32.3%
+32.3%

More News

Read More
News headline image
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Via Chartmill
News headline image
Earnings Scheduled For November 10, 2025 ↗
Via Benzinga
Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside ↗
Via Stocktwits
News headline image
Demystifying Harrow: Insights From 5 Analyst Reviews ↗
Via Benzinga
News headline image
Could Harrow's New Sedation Pill Change Millions Of Medical Procedures Forever? ↗
Via Benzinga
News headline image
Tesla To Rally Around 4%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
Via Benzinga
News headline image
HARROW INC (NASDAQ:HROW) Presents High Growth Momentum and Technical Breakout Opportunity ↗
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
A Preview Of Harrow's Earnings ↗
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
Earnings Scheduled For August 11, 2025 ↗
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
From Harrow, Inc.
Via Business Wire
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire
News headline image
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Harrow, Inc. – HROW
From Pomerantz LLP
Via GlobeNewswire

Frequently Asked Questions

Is Harrow, Inc. - Common Stock publicly traded?
Yes, Harrow, Inc. - Common Stock is publicly traded.
What exchange does Harrow, Inc. - Common Stock trade on?
Harrow, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harrow, Inc. - Common Stock?
The ticker symbol for Harrow, Inc. - Common Stock is HROW on the Nasdaq Stock Market
What is the current price of Harrow, Inc. - Common Stock?
The current price of Harrow, Inc. - Common Stock is 44.47
When was Harrow, Inc. - Common Stock last traded?
The last trade of Harrow, Inc. - Common Stock was at 01/23/26 04:00 PM ET
What is the market capitalization of Harrow, Inc. - Common Stock?
The market capitalization of Harrow, Inc. - Common Stock is 1.65B
How many shares of Harrow, Inc. - Common Stock are outstanding?
Harrow, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.